内质网应激通过神经炎症参与小鼠骨癌痛
该研究在小鼠骨癌痛模型中探索内质网应激与神经炎症在疼痛发生中的作用。鞘内注射TNF-α或脂多糖可增加内质网应激标志物,而鞘内注射内质网应激抑制剂4-PBA或GSK2606414可产生时间与剂量依赖性镇痛作用,并减少炎症介质表达和星形胶质细胞活化。提示抑制脊髓神经元内质网应激可减轻骨癌痛。
要点
- 骨癌痛小鼠脊髓神经元中p-PERK和p-eIF2α表达增加,伴炎症介质升高。
- 鞘内注射4-PBA或GSK2606414可产生时间与剂量依赖性镇痛作用。
- 抑制内质网应激减少脊髓炎症介质表达和星形胶质细胞活化。
核心结论
- 抑制炎症介质触发的脊髓神经元内质网应激可通过调节神经炎症减轻骨癌痛。
研究设计与样本
- 采用雄性小鼠骨癌痛模型;对照小鼠鞘内注射TNF-α和脂多糖,骨癌痛小鼠鞘内注射内质网应激抑制剂4-PBA和GSK2606414;评估痛行为、内质网应激标志物和炎症介质。
主要发现
- 骨癌痛期间脊髓神经元中p-RNA依赖蛋白激酶样内质网激酶和p-真核起始因子2α表达增加,同时TNF-α、白介素1β和白介素6上调。
- 对照小鼠鞘内注射TNF-α或脂多糖可增加内质网应激标志物表达。
- 鞘内注射4-PBA后,基线 vs. 3小时:缩足机械阈值0.34 ± 0.16 g vs. 1.65 ± 0.40 g,自发缩足次数8.00 ± 1.20次/2分钟 vs. 0.88 ± 0.64次/2分钟,P < 0.001,n = 8。
- 鞘内注射GSK2606414后,基线 vs. 3小时:缩足机械阈值0.37 ± 0.08 g vs. 1.38 ± 0.11 g,自发缩足次数8.00 ± 0.93次/2分钟 vs. 3.25 ± 1.04次/2分钟,P < 0.001,n = 8。
- 4-PBA或GSK2606414治疗后,TNF-α、白介素1β和白介素6表达减少,脊髓星形胶质细胞活化降低。
临床怎么用
- 靶向脊髓神经元内质网应激可能成为骨癌痛镇痛的新策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prolonged endoplasmic reticulum stress has been identified in various diseases. Inflammatory mediators, which have been shown to induce endoplasmic reticulum stress in several studies, have been suggested to serve as the important modulators in pain development. In this study, the authors hypothesized that the endoplasmic reticulum stress triggered by inflammatory mediators contributed to pain development. METHODS: The authors used a male mouse model of bone cancer pain. The control mice were intrathecally injected with tumor necrosis factor-α (TNF-α) and lipopolysaccharide, the bone cancer pain mice were intrathecally injected with the endoplasmic reticulum stress inhibitors 4-PBA and GSK2606414. The nociceptive behaviors, endoplasmic reticulum stress markers, and inflammatory mediators were assessed. RESULTS: Increased expression of the p-RNA-dependent protein kinase-like endoplasmic reticulum kinase and p-eukaryotic initiation factor 2α were found in the spinal neurons during bone cancer pain, along with upregulation of inflammatory mediators (TNF-α, interleukin 1β, and interleukin 6). Intrathecal administration of TNF-α or lipopolysaccharide increased the expression of endoplasmic reticulum stress markers in control mice. Inhibition of endoplasmic reticulum stress by intrathecal administration of 4-PBA (baseline vs. 3 h: 0.34 ± 0.16 g vs. 1.65 ± 0.40 g in paw withdrawal mechanical threshold, 8.00 ± 1.20 times per 2 min vs. 0.88 ± 0.64 times per 2 min in number of spontaneous flinches, P < 0.001, n = 8) or GSK2606414 (baseline vs. 3 h: 0.37 ± 0.08 g vs. 1.38 ± 0.11 g in paw withdrawal mechanical threshold, 8.00 ± 0.93 times per 2 min vs. 3.25 ± 1.04 times per 2 min in number of spontaneous flinches, P < 0.001, n = 8) showed time- and dose-dependent antinociception. Meanwhile, decreased expression of inflammatory mediators (TNF-α, interleukin 1β, and interleukin 6), as well as decreased activation of astrocytes in the spinal cord, were found after 4-PBA or GSK2606414 treatment. CONCLUSIONS: Inhibition of inflammatory mediator-triggered endoplasmic reticulum stress in spinal neurons attenuates bone cancer pain via modulation of neuroinflammation, which suggests new approaches to pain relief.
引用
- Mao Y, Wang C, Tian X, et al. Endoplasmic Reticulum Stress Contributes to Nociception via Neuroinflammation in a Murine Bone Cancer Pain Model. Anesthesiology. 2020. PMID: 31939851. doi:10.1097/ALN.0000000000003078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。